For the year ending 2025-11-30, NRIX made $83,980K in revenue. -$264,457K in net income. Net profit margin of -314.90%.
| Income Statement | 2025-11-30 | |||
|---|---|---|---|---|
| Total revenue | 83,980 | |||
| Research and development | 316,903 | |||
| General and administrative | 52,743 | |||
| Total operating expenses | 369,646 | |||
| Loss from operations | -285,666 | |||
| Interest and other income, net | 21,969 | |||
| Loss before income taxes | -263,697 | |||
| Provision for income taxes | 760 | |||
| Net loss | -264,457 | |||
| Net loss per share, basic (in usd per share) | -3.05 | |||
| Net loss per share, diluted (in usd per share) | -3.05 | |||
| Weighted-average number of shares outstanding, basic (in shares) | 86,666,907 | |||
| Weighted-average number of shares outstanding, diluted (in shares) | 86,666,907 | |||
Nurix Therapeutics, Inc. (NRIX)
Nurix Therapeutics, Inc. (NRIX)